OncoVEXmGM-CSFexpands tumor antigen-specific CD8+ T-cell response in preclinical models. - Estrada J; Zhan J; Mitchell P; Werner J; Beltran PJ; DeVoss J; Qing J; Cooke KS (Journal for immunotherapy of cancer, 2023)